BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6995362)

  • 1. Possible systemic metabolic effects of regional adiposity in a patient with Werner's syndrome.
    Smith U; Digirolamo M; Blohmé G; Kral JG; Tisell LE
    Int J Obes; 1980; 4(2):153-63. PubMed ID: 6995362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic studies in a case of Werner's syndrome.
    Blohmé G; Smith U
    Diabete Metab; 1979 Jun; 5(2):119-24. PubMed ID: 478081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced intra-abdominal visceral fat accumulation in patients with Werner's syndrome.
    Mori S; Murano S; Yokote K; Takemoto M; Asaumi S; Take A; Saito Y
    Int J Obes Relat Metab Disord; 2001 Feb; 25(2):292-5. PubMed ID: 11410834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.
    Krotkiewski M; Björntorp P; Sjöström L; Smith U
    J Clin Invest; 1983 Sep; 72(3):1150-62. PubMed ID: 6350364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.
    Weyer C; Foley JE; Bogardus C; Tataranni PA; Pratley RE
    Diabetologia; 2000 Dec; 43(12):1498-506. PubMed ID: 11151758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism in isolated fat cells: enhanced response of larger adipocytes from older rats to epinephrine and adrenocorticotropin.
    DiGirolamo M; Owens JL
    Horm Metab Res; 1976 Nov; 8(6):445-51. PubMed ID: 187534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women.
    Pouliot MC; Després JP; Nadeau A; Tremblay A; Moorjani S; Lupien PJ; Thériault G; Bouchard C
    Int J Obes; 1990 Apr; 14(4):293-302. PubMed ID: 2361806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of adipose tissue distribution in humans.
    Björntorp P
    Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
    Gjedsted J; Gormsen LC; Nielsen S; Schmitz O; Djurhuus CB; Keiding S; Ørskov H; Tønnesen E; Møller N
    Acta Physiol (Oxf); 2007 Nov; 191(3):205-16. PubMed ID: 17784905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes.
    Hansen BC; Jen KL; Schwartz J
    Int J Obes; 1988; 12(5):433-43. PubMed ID: 3069766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.
    Zamboni M; Armellini F; Milani MP; De Marchi M; Todesco T; Robbi R; Bergamo-Andreis IA; Bosello O
    Int J Obes Relat Metab Disord; 1992 Jul; 16(7):495-504. PubMed ID: 1323546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
    Mauriège P; Klein Kranenbarg WM; Prud'homme D; Lamarche B; Tremblay A; Bouchard C; Nadeau A; Després JP
    Int J Obes Relat Metab Disord; 1996 Jul; 20(7):668-76. PubMed ID: 8817361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Werner's syndrome: metabolic observations.
    Alberti KG; Young JD; Hockaday TD
    Proc R Soc Med; 1974 Jan; 67(1):36-8. PubMed ID: 4821593
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone binding protein in Werner's syndrome.
    Hattori N; Hino M; Ikekubo K; Ishihara T; Moridera K; Kurahachi H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):351-3. PubMed ID: 1424167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of insulin resistance associated with Werner's syndrome.
    Vannini P; Ciavarella A; Forlani G; Mustacchio A; Patrono D; Capelli M
    Diabete Metab; 1987 Apr; 13(2):81-5. PubMed ID: 3297836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes.
    Giugliano D; Torella R; Improta L; Scognamiglio G
    Farmaco Prat; 1979 Jan; 34(1):32-41. PubMed ID: 378687
    [No Abstract]   [Full Text] [Related]  

  • 20. Werner's syndrome: a model of premature aging?
    Beadle GF; Mackay IR; Whittingham S; Taggart G; Harris AW; Harrison LC
    J Med; 1978; 9(5):377-404. PubMed ID: 311372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.